Skip to main content
. 2014 Aug 18;15(8):14396–14410. doi: 10.3390/ijms150814396

Figure 1.

Figure 1

Measurement of mice body weight. During the treatment, no significant difference in bodyweight was observed among control, Alzheimer’s disease-like (AD-like)miceand sulforaphane-treated Alzheimer’s disease-like (AD+SFN-like) mice (n = 18; mean ± S.E.M.; One-way analysis of variance followed by post hoc least significant difference multiple comparison tests).